CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.
To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Wei M et al. | [Analysis of gene expression patterns of leukemia K562 cells after cytochalasin B treatment]. | 2003 | Ai Zheng | pmid:12654177 |
Naef A | The relationship between the transient cAMP peak and various leucocyte responses. | 1983 | Agents Actions Suppl. | pmid:6301236 |
Fantozzi R et al. | FMLP-activated neutrophils evoke histamine release from mast cells. | 1986 | Agents Actions | pmid:2425573 |
Tasaka K et al. | Distribution of actin filaments in rat mast cells and its role in histamine release. | 1986 | Agents Actions | pmid:2425590 |
Marone G et al. | Histamine release from human basophils by pepstatin A. | 1985 | Agents Actions | pmid:2413738 |
Baggiolini M et al. | Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes. | 1985 | Agents Actions | pmid:2996321 |
Roos D et al. | Dissociation of phagocytosis, metabolic stimulation and lysosomal enzyme release in human leukocytes. | 1976 | Agents Actions | pmid:181968 |
Mannaioni PF et al. | Studies on the 14C-histamine release induced by noradrenaline in mouse neoplastic mast cells. | 1975 | Agents Actions | pmid:56875 |
Moroni F et al. | Studies on the 14C-histamine release induced by histamine in mouse neoplastic mast cells. | 1975 | Agents Actions | pmid:56876 |
Schnitzler S et al. | Histamine release from rat mast cells induced by protamine sulfate and polyethylene imine. | 1981 | Agents Actions | pmid:6166172 |